
Keywords: دقت گاما کربوکسی پروترومبین; BMI; body mass index; DCP; des-gamma-carboxy prothrombin; DDLT; deceased donor liver transplantation; HCC; hepatocellular carcinoma; LDLT; living donor liver transplantation; LT; liver transplantation; MELD; model for end-stage liver disease; MSMC; Mount